These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23891320)

  • 21. Inhibition of corneal neovascularization with plasmid pigment epithelium-derived factor (p-PEDF) delivered by synthetic amphiphile INTeraction-18 (SAINT-18) vector in an experimental model of rat corneal angiogenesis.
    Kuo CN; Yang LC; Yang CT; Lai CH; Chen MF; Chen CY; Chen CH; Wu PC; Kou HK; Chen YJ; Hung CH; Tsai CB
    Exp Eye Res; 2009 Nov; 89(5):678-85. PubMed ID: 19596319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrinolysis components and angiogenesis regulation by example of burn-induced corneal neovascularization in rabbits].
    Chesnokova NB; Aĭsina RB; Mukhametova LI; Pavlenko TA; Gulin DA; Beznos OV
    Vestn Oftalmol; 2012; 128(4):62-5. PubMed ID: 22994111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal Indocyanine Green Angiography to Guide Medical and Surgical Management of Corneal Neovascularization.
    Steger B; Romano V; Kaye SB
    Cornea; 2016 Jan; 35(1):41-5. PubMed ID: 26555579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
    Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
    Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediators of neovascularization and the hypoxic cornea.
    Safvati A; Cole N; Hume E; Willcox M
    Curr Eye Res; 2009 Jun; 34(6):501-14. PubMed ID: 19899985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of corneal neovascularization with propolis extract.
    Keshavarz M; Mostafaie A; Mansouri K; Shakiba Y; Motlagh HR
    Arch Med Res; 2009 Jan; 40(1):59-61. PubMed ID: 19064129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.
    Samolov B; Steen B; Seregard S; van der Ploeg I; Montan P; Kvanta A
    Exp Eye Res; 2005 Feb; 80(2):159-66. PubMed ID: 15670794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corneal lymphangiogenesis: implications in immunity.
    Patel SP; Dana R
    Semin Ophthalmol; 2009; 24(3):135-8. PubMed ID: 19437348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic ablation of CD36 induces age-related corneal neovascularization.
    Mwaikambo BR; Sennlaub F; Ong H; Chemtob S; Hardy P
    Cornea; 2008 Oct; 27(9):1037-41. PubMed ID: 18812768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methods of diagnosis and treatment of corneal neovascularization].
    Malyugin BE; Isabekov RS; Kalinnikova SY; Antonova OP
    Vestn Oftalmol; 2023; 139(4):86-92. PubMed ID: 37638577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn.
    Yoeruek E; Ziemssen F; Henke-Fahle S; Tatar O; Tura A; Grisanti S; Bartz-Schmidt KU; Szurman P;
    Acta Ophthalmol; 2008 May; 86(3):322-8. PubMed ID: 17995975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Confocal microscopy of corneal graft rejection.
    Cohen RA; Chew SJ; Gebhardt BM; Beuerman RW; Kaufman HE; Kaufman SC
    Cornea; 1995 Sep; 14(5):467-72. PubMed ID: 8536459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.
    Philipp W; Speicher L; Humpel C
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2514-22. PubMed ID: 10937562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental approaches to study in vivo angiogenesis].
    Kilarski W; Bikfalvi A
    Bull Cancer; 2007 Jul; 94 Spec No():S166-9. PubMed ID: 17846001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo measurement of corneal angiogenesis with video data acquisition and computerized image analysis.
    Conrad TJ; Chandler DB; Corless JM; Klintworth GK
    Lab Invest; 1994 Mar; 70(3):426-34. PubMed ID: 7511717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
    Hosseini H; Nejabat M
    Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis.
    Bachmann B; Taylor RS; Cursiefen C
    Ophthalmology; 2010 Jul; 117(7):1300-5.e7. PubMed ID: 20605214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.
    Cursiefen C; Colin J; Dana R; Diaz-Llopis M; Faraj LA; Garcia-Delpech S; Geerling G; Price FW; Remeijer L; Rouse BT; Seitz B; Udaondo P; Meller D; Dua H
    Br J Ophthalmol; 2012 Jan; 96(1):3-9. PubMed ID: 21712359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The heparan sulfate suleparoide inhibits rat corneal angiogenesis and in vitro neovascularization.
    Benelli U; Bocci G; Danesi R; Lepri A; Bernardini N; Bianchi F; Lupetti M; Dolfi A; Campagni A; Agen C; Nardi M; Del Tacca M
    Exp Eye Res; 1998 Aug; 67(2):133-42. PubMed ID: 9733580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.